$MDNA $MDNAF Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctio...

Bio Stocks™· @BioStocks · X·2026-04-21 19:33· 2026-04-21Score60

Body · original

$MDNA $MDNAF Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at #AACR26

Heat 27 · 20 likes · 1 reply · 6 reposts

Conference abstracts

4342matched by 代号 MDNA113

MDNA113 is a masked conditionally activated tumor-targeted anti-PD1-IL-2SK with superior safety and therapeutic properties

Minh D. To, Rosemina Merchant, Aanchal Sharma, Fahar Merchant

Read the abstract →

Source: Bio Stocks™ · x.com